bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 691 shares, a decline of 39.1% from the June 30th total of 1,134 shares. Based on an average daily trading volume, of 614 shares, the short-interest ratio is currently 1.1 days.
bioAffinity Technologies Trading Down 2.9%
NASDAQ BIAFW traded down $0.00 during trading hours on Thursday, reaching $0.09. The company had a trading volume of 110 shares, compared to its average volume of 2,406. The stock has a 50-day moving average of $0.14 and a 200 day moving average of $0.24. bioAffinity Technologies has a 1-year low of $0.05 and a 1-year high of $0.81.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
Further Reading
- Five stocks we like better than bioAffinity Technologies
- DoorDash’s Drone Certification Could Reshape Its Delivery Margins
- 2 Unique Space ETFs That Could Upend the Industry
- Corning Stock Crashes on Earnings, But the Sell-Off Looks Overdone
- Palantir’s Earnings Setup Puts Its AI Growth Story Back on Trial Again
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
